Pulmocide is currently owned by Jeito Capital, through Jeito I, since 2021.

When did Jeito Capital acquire Pulmocide?

Jeito Capital acquired Pulmocide in 2021 (active for 5 years).

Pulmocide

Biotech·

United Kingdom·Active·5yr hold

Pulmocide is a healthcare company, headquartered in France.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

HQFrance

SectorHealthcare

London-based biotech developing inhaled antifungal and antiviral therapies for serious respiratory infections; Jeito Capital backed in 2021.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Jeito I

6 comparable biotech deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings